Morgan Stanley
NSPR icon

Morgan Stanley’s InspireMD NSPR Stock Holding History

Morgan Stanley’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.9K Sell
39,836
-1,997
-5% -$3.41K ﹤0.01% 6315
2025
Q4 		$74.5K Sell
41,833
-44,178
-51% -$92.1K ﹤0.01% 6303
2025
Q3 		$207K Sell
86,011
-8,130
-9% -$19.7K ﹤0.01% 5872
2025
Q2 		$214K Buy
94,141
+22,875
+32% +$57K ﹤0.01% 5821
2025
Q1 		$192K Sell
71,266
-53,035
-43% -$150K ﹤0.01% 5744
2024
Q4 		$327K Buy
124,301
+34,807
+39% +$93.6K ﹤0.01% 5592
2024
Q3 		$240K Buy
89,494
+500
+0.6% +$1.36K ﹤0.01% 5684
2024
Q2 		$222K Buy
88,994
+25,464
+40% +$59.6K ﹤0.01% 5619
2024
Q1 		$151K Sell
63,530
-63,530
-50% -$171K ﹤0.01% 5834
2023
Q4 		$357K Buy
127,060
+81,560
+179% +$235K ﹤0.01% 5743
2023
Q3 		$149K Buy
45,500
+35,500
+355% +$113K ﹤0.01% 5707
2023
Q2 		$25.1K Buy
+10,000
New +$15.9K ﹤0.01% 6492
2022
Q2 		– Sell
-450
Closed -$1K – 7915
2022
Q1 		$1K Hold
450
– – ﹤0.01% 7855
2021
Q4 		$1K Hold
450
– – ﹤0.01% 7876
2021
Q3 		$2K Hold
450
– – ﹤0.01% 7672
2021
Q2 		$2K Sell
450
-156
-26% -$945 ﹤0.01% 7531
2021
Q1 		$7K Buy
+606
New +$7.21K ﹤0.01% 7037
2019
Q4 		– Sell
-909
Closed -$18K – 6722
2019
Q3 		$18K Buy
+909
New +$36.7K ﹤0.01% 6045
2019
Q2 		– Hold
0
– – – 6706
2019
Q1 		– Sell
-1
Closed -$129 – 6666
2018
Q4 		$0 Hold
1
– – ﹤0.01% 6677
2018
Q3 		$0 Hold
1
– – ﹤0.01% 6766
2018
Q2 		$0 Sell
1
-1
-50% -$849 ﹤0.01% 6718
2018
Q1 		$1K Buy
+2
New +$6.89K ﹤0.01% 6546
2017
Q2 		– Hold
0
– – – 6626
2017
Q1 		– Hold
0
– – – 6595
2016
Q4 		– Hold
0
– – – 6545
2016
Q3 		– Hold
0
– – – 6541
2016
Q2 		– Hold
0
– – – 6434
2016
Q1 		– Hold
0
– – – 6474
2015
Q4 		– Hold
0
– – – 6508
2015
Q3 		– Hold
0
– -$1K – 6680
2015
Q2 		– Hold
0
– – – 6572
2015
Q1 		– Hold
0
– – – 6398
2014
Q4 		– Hold
0
– – – 6255
2014
Q3 		– Hold
0
– – – 5962
2014
Q2 		– Hold
0
– – – 6131
2014
Q1 		– Hold
0
– – – 6126
2013
Q4 		– Hold
0
– – – 6023

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Morgan Stanley's NSPR Position: Q1 2026 in Review

Morgan Stanley reduced its InspireMD (NSPR) stake by 4.8% in Q1 2026, selling an estimated $3.41K and leaving 39,836 shares worth $64.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6315.

Morgan Stanley first reported a position in NSPR in Q1 2018 and has held it in 22 quarters since. The position peaked at $357K in Q4 2023. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Morgan Stanley held 39,836 shares of InspireMD worth $64.9K as of Q1 2026.
  • Morgan Stanley sold 1,997 InspireMD shares in Q1 2026, an estimated $3.41K.
  • InspireMD made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6315 holding.
  • Morgan Stanley first reported a position in InspireMD in Q1 2018 and has held it in 22 quarters since.
  • Morgan Stanley's InspireMD position peaked at $357K in Q4 2023.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.